Brijendra K. Srivastava, MBBS, MSc, FRCP (Edin & Glasg), FACE

Deputy Director & Senior Consultant
MADRAS DIABETES RESEARCH FOUNDATION, India

Poster(s):

• (2.07) Initial experience with Minimed 780G system in type 2 diabetic individuals at a tertiary diabetes centre in south India
  Thursday, May 9, 2024

  10:45 AM – 11:00 AM CDT

• (2.08) Effect of combination therapy with once weekly Dulaglutide and Empagliflozin on noninvasive liver scores: real world experience from India
  Thursday, May 9, 2024

  10:45 AM – 11:00 AM CDT